TIAM2
GILD icon

Tru Independence Asset Management 2’s Gilead Sciences GILD Stock Holding History

Tru Independence Asset Management 2’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-304
Closed -$18K – 221
2020
Q4 		$18K Buy
+304
New +$18.3K 0.02% 266

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Tru Independence Asset Management 2's GILD Position: Q1 2021 in Review

Tru Independence Asset Management 2 sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 304 shares — an estimated $18K sold.

Tru Independence Asset Management 2 first reported a position in GILD in Q4 2020 and held it in 1 quarter. The position peaked at $18K in Q4 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • Tru Independence Asset Management 2 reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • Tru Independence Asset Management 2 sold 304 Gilead Sciences shares in Q1 2021, an estimated $18K.
  • Tru Independence Asset Management 2 first reported a position in Gilead Sciences in Q4 2020 and held it in 1 quarter.
  • Tru Independence Asset Management 2's Gilead Sciences position peaked at $18K in Q4 2020.
  • 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Tru Independence Asset Management 2's 13F filing for Q1 2021, filed 19 May 2021.